Ethnic disparities in cervical cancer illness burden and subsequent care: A prospective view in managed care

American Journal of Managed Care

Volumn 14, Issue SUPPL. 6, 2008, Pages

  Smith, Jennifer S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; ASIAN AMERICAN; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; COST OF ILLNESS; CULTURAL FACTOR; ETHNIC GROUP; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DISTRIBUTION; HEALTH INSURANCE; HUMAN; LOWEST INCOME GROUP; MANAGED CARE; MONEY; PACIFIC ISLANDER; PAPANICOLAOU TEST; PRIMARY PREVENTION; PRIORITY JOURNAL; RACISM; RISK FACTOR; SECONDARY PREVENTION; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADULT; COST OF ILLNESS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MANAGED CARE PROGRAMS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 46049113709     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. American Cancer Society. Detailed guide: cervical cancer. http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=8. Accessed May 13, 2008.
2. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics. 2005;23(11):1107-1122.
3. US National Institutes of Health, National Cancer Institute. Human papillomavirus vaccines: questions and answers. http://www.nci.nih.gov/ cancertopics/factsheet/risk/HPV-vaccine. Accessed May 13, 2008.
4. US National Institutes of Health, National Cancer Institute, Surveillance Epidemiology and End Results (SEER). Cancer stat fact sheets: cancer of the cervix uteri. http://seer.cancer.gov/statfacts/html/cervix.html. Accessed May 13, 2008.
5. Miller BA, Kolonel LN, Bernstein L, et al, eds. Racial/Ethnic Patterns of Cancer in the United States 1988-1992, National Cancer Institute. NIH Pub. No. 96-4104. Bethesda, MD; 1996.
6. Eschbach K, Kuo YF, Goodwin JS. Ascertainment of Hispanic ethnicity on California death certificates: implications for the explanation of the Hispanic mortality advantage. Am J Public Health. 2006;96(12):2209-2215.
7. Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer. 2007;31(3):157-181.
8. National Institutes of Health, Center to Reduce Cancer Health Disparities. Excess cervical cancer mortality: a marker for low access to health care in poor communities. http://crchd.cancer.gov/attachments/excess- cervcanmort.pdf. Accessed May 13, 2008.
9. National Committee for Quality Assurance. The state of health care quality 2006. http://www.ncqa.org/tabid/447/Default.aspx. Accessed May 13, 2008.
10. Centers for Disease Control and Prevention. DATA2010: the Healthy People 2010 database. http://wonder.cdc.gov/DATA2010/. Accessed May 13, 2008.
11. Byrd TL, Chavez R, Wilson KM. Barriers and facilitators of cervical cancer screening among Hispanic women. Ethn Dis. 2007;17(1):129-134.
12. Ponce NA, Chawla N, Babey SH, et al. Is there a language divide in Pap test use? Med Care. 2006;44(11):998-1004.
13. American Cancer Society. Cancer prevention & early detection facts and figures 2007. http://www.cancer.org/downloads/STT/ CPED2007PWSecuredCPED.pdf. Accessed May 13, 2008.
14. Echeverria SE, Carrasquillo O. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women. Med Care. 2006;44(8):788-792.
15. Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA. 1994;272(7):530-534.
16. Coughlin SS, Uhler RJ, Richards T, Wilson KM. Breast and cervical cancer screening practices among Hispanic and non-Hispanic women residing near the United States-Mexico border, 1999-2000. Fam Community Health. 2003;26(2):130-139.
17. O'Malley CD, Shema SJ, Clarke LS, Clarke CA, Perkins CI. Medicaid status and stage at diagnosis of cervical cancer. Am J Public Health. 2006;96(12):2179-2185.
18. Eggleston KS, Coker AL, Das IP, Cordray ST, Luchok KJ. Understanding barriers for adherence to follow-up care for abnormal pap tests. J Womens Health (Larchmt). 2007;16(3):311-330.
19. Engelstad LP, Stewart SL, Nguyen BH, et al. Abnormal Pap smear follow-up in a high-risk population. Cancer Epidemiol Biomarkers Prev. 2001;10(10):1015-1020.
20. Harlan LC, Greene AL, Clegg LX, Mooney M, Geiger AM, Mangione CM. Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol. 2005;23(36):9079-9088.
21. Nelson K, Geiger AM, Mangione CM. Effect of health beliefs on delays in care for abnormal cervical cytology in a multi-ethnic population. J Gen Intern Med. 2002;17(9):709-716.
22. Lerman C, Hanjani P, Caputo C, et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol. 1992;10(2):330-333.
23. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2007;109(2 pt 1):360-370.
24. Morgan MA, Behbakht K, Benjamin I, Berlin M, King SA, Rubin SC. Racial differences in survival from gynecologic cancer. Obstet Gynecol. 1996;88:914-918.
25. Schwartz KL, Crossley-May H, Vigneau FD, Brown K, Banerjee M. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Contr. 2003;14(8):761-766.
26. Bradley CJ, Given CW, Roberts C. Health care disparities and cervical cancer. Am J Public Health. 2004;94(12):2098-2103.
27. Farley JH, Hines JF, Taylor RR, et al. Equal care ensures equal survival for African American women with cervical carcinoma. Cancer. 2001;91(4):869-873.